Eastman Chemical CO Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 5.22% beneficial ownership stake in Eastman Chemical Co.
NYSE
Vanguard Portfolio Management has disclosed a beneficial ownership of 6.7% in Eastman Chemical Company's common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G for Eastman Chemical Co, reporting 0% beneficial ownership due to an internal organizational realignment.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 11.9% in Eastman Chemical Co.
NYSE
Capital Research Global Investors filed an amendment to its Schedule 13G, disclosing a 3.7% beneficial ownership stake in Eastman Chemical Co.
NYSE
Franklin Resources, Inc. reports a 3.9% beneficial ownership stake in Eastman Chemical Company common stock in an amended Schedule 13G filing.
NYSE
Franklin Resources, Inc. and its affiliates have reported a 5.1% beneficial ownership stake in Eastman Chemical Company, held for investment purposes in the ordinary course of business.
NYSE
SCHEDULE 13G: Capital Research Global Investors Discloses 5.1% Passive Stake in Eastman Chemical Co.
Capital Research Global Investors has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in Eastman Chemical Co. as of December 31, 2024, held for ordinary course investment purposes.